Predicting Your Health

Mayer, Kathy
November 2008
Indiana Business Magazine;Nov2008, Vol. 52 Issue 11, p76
The article discusses the new clinical test from life sciences company Predictive Physiology & Medicine Inc. (PPM) in Indiana. PPM launched its Viveda Cardio analysis to Indiana's medical practices, executive health programs, and wellness and sports medicine centers. This new blood analysis technology is said to be more cost-effective and comprehensive than the current clinical blood tests.


Related Articles

  • Partec cites gains with CyFlow.  // Medical Device Daily;12/10/2008, Vol. 12 Issue 219, p7 

    The article reports on the successful use of CyFlow instruments of Partec by people living with HIV/AIDS. It was noted that 2.5 million patient tests have been performed with the system in 2008. The company said that the with the introduction of the Partec innovation, the average cost per...

  • Opportunities and Challenges Offered by Cell-Free Fetal DNA Testing and Non-Invasive Prenatal Testing. Fehrs-Battey, Amber // Laboratory Medicine;Winter2013, Vol. 44 Issue 1, pe43 

    Non-invasive prenatal testing has the potential to bring changes to the clinical laboratory industry. The ability to isolate cell-free fetal DNA and perform molecular-based testing presents challenges. Clinical laboratories will need to research these tests to avoid being left behind, to...

  • Cancer And The New Science Of Early Detection. Goetz, Thomas; Trochut, Alex; Alejo, Mauricio; Schittny, Burkhard // Wired;Jan2009, Vol. 17 Issue 1, p79 

    The article focuses on the technologies for the early detection of cancer. Researchers are refining protein tests that can pick up molecular changes in the bloodstream and are testing next-generation imaging techniques that can identify and isolate a tumor within the body. These technologies...

  • Basics of home glucose monitoring. Townsend, Louise // MLO: Medical Laboratory Observer;Feb2008, Vol. 40 Issue 2, p32 

    The article focuses on home glucose monitoring instruments that are used in supervising the levels of diabetes and the health condition of diabetic patients in general. These medical instruments are allegedly now small enough to fit in the palm of a patient's hand. They also include a clock and...

  • LightCycler SeptiFast technology in patients with solid malignancies: clinical utility for rapid etiologic diagnosis of sepsis. Dubská, Lenka; Vysko&#c010D;ilová, Martina; Minaříková, Dagmar; Jelínek, Petr; Tejkalová, Renata; Valík, Dalibor // Critical Care;2012, Vol. 16 Issue 1, p10595 

    The article discusses a retrospective study evaluating the results of the LightCycler SeptiFast test from patients with solid malignancy admitted to the intensive care unit (ICU) between June 2009 and August 2011 to ascertain its clinical utility for rapid etiologic diagnosis of sepsis. Topics...

  • ApoCell Launches Revolutionary Circulating Cancer Cell Detection System.  // Biomedical Market Newsletter;6/9/2011, p1128 

    The article reports on the announcement by ApoCell Inc. that it has completed its revolutionary technology for detecting cancer cells in the blood. It states that the technology which is invented by Laboratory of Diagnostic Microsystems of the University of Texas, captures circulating tumor...

  • The need for speed. Mantone, Joseph // Modern Healthcare;8/9/2004, Vol. 34 Issue 32, p30 

    Discusses medical advances in blood testing for diagnostic processes. Benefit of rapid blood tests to diagnostic effectiveness; Example of critical conditions that companies target for testing development; Information on a published research that has supported HIV tests.

  • Start-up Firm Harvests Exosomes from Blood to Diagnose Cancer. Theodora, Daria // BioWorld Today;12/29/2008, Vol. 19 Issue 250, p1 

    The article reports on the plans of Exosome Diagnostics Inc. to develop a series of blood-based oncology diagnostics that can offer extensive tumor profiling. It explains the concept behind the test. It references a study published in the November 16, 2008 advanced online edition of "Nature Cell...

  • Accidental Diagnosis of Multiple Myeloma in a 44-Year-Old White Woman due to Erroneous Results via Chemical Analyzers. Bashiti, Ola // Laboratory Medicine;2016, Vol. 47 Issue 1, pe5 

    Patient: 44-year-old white woman. Chief Complaints: Cramping, nausea, shortness of breath, visual disturbances ("seeing yellow dots"). Medical History: Status asthmticus, tobacco use, hypertension, migraines. Principle Laboratory Findings: Tables 1-7, Figures 1-4.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics